Analysts forecast the Global Transcriptomics market will grow at a CAGR of 15.8 percent over the period 2013-2018.
The Report recognizes the following companies as the key players in Global Transcriptomics Market: Abbott Laboratories, Affymetrix Inc., Agilent Technologies Inc., F. Hoffmann-La Roche Ltd., Illumina Inc., Thermo Fisher Scientific Inc., Biological Industries Ltd., Bio-Rad Laboratories Inc., Cytognomix Inc.,Kreatech Inc., Molecular Devices LLC, Oxford Gene Technology Ltd., Qiagen N. V., SciGene Corp. , Sigma-Aldrich Co. LLC.
The increased incidence of cardiovascular, CNS disorders, and cancer leads to increased demand for improved quality tools and systems for diagnostics and drug discovery. Gene expression patterns and gene regulation mechanisms, which trigger the functioning and production of proteins, can be studied using transcriptomics, and the therapeutic target can be identified more accurately. The increasing demand for personalized medicines, transcriptomics technologies, and continuous improvements in healthcare infrastructures is the encouraging factor for drug discovery and research. Pharmaceutical and biotechnology companies, such as F. Hoffmann-La Roche Ltd., Affymetrix, Illumina, and Abbott Laboratories, are investing a huge amount in medical research to develop strong tools and services.
Purchase a Copy of this Report Directly at http://bit.ly/1q23NIo
Covered in this Report
This report covers the present scenario and the growth prospects of the Global Transcriptomics market for the period 2014-2018. To calculate the market size, the report considers revenue generated from the sales of products used for research and diagnostics. The products employed in the use microarray, PCR, NGS and RNAi techniques are considered within the scope of the report.
Global Transcriptomics Market 2014-2018, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions with individual country-wise revenue segmentation; it also covers the Global Transcriptomics market landscape and its growth prospects in the coming years. The report also includes a share of the key vendors operating in this market.
According to the report, one of the major factors driving the market is the advances in transcriptomics technology. Due to improved accuracy, sensitivity, specificity, and diagnostic speed the use of transcriptomics tools is increasing.
Further, the report states that one of the major challenges is the unmet technological need for transcriptomics technologies in clinical diagnostics and research studies. For example, NGS shows limitations in the sequencing of a homopolymer region in genome sequencing, which leads to incorrect data interpretation.
Inquire Before Buying the Report at http://bit.ly/1klnWpd
- Abbott Laboratories
- Affymetrix Inc.
- Agilent Technologies Inc.
- F. Hoffmann-La Roche Ltd.
- Illumina Inc.
- Thermo Fisher Scientific Inc.
Other Prominent Vendors
- Biological Industries Ltd.
- Bio-Rad Laboratories Inc.
- Cytognomix Inc.
- Kreatech Inc.
- Molecular Devices LLC
- Oxford Gene Technology Ltd.
- Qiagen N. V.
- SciGene Corp.
- Sigma-Aldrich Co. LLC
Key Market Driver
- Advancement in Transcriptomics Technology
Key Market Challenge
- Unmet Technological Needs
Key Market Trend
- Comprehensive Focus on Drug Discovery and Disease Diagnosis
Key Questions Answered in this Report
- What will the market size be in 2018 and what will the growth rate be?
- What are the key market trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?